Feed Preview

Inflammatory Breast Neoplasms

Inflammatory Breast Neoplasms diagram by undefined

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

Top 20 most recent papers
The Lancet Oncology

Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial

The Lancet OncologySeptember 30, 2019
Aung NaingNizar M Tannir
38
11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyAugust 28, 2019
Jennifer Keating LittonBanu K. Arun
85
2
7
Frontiers in Immunology

Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer

Frontiers in ImmunologyAugust 29, 2019
Leandro Marcelo MartinezPaula D Bos
49
Scientific Reports

Neutrophil activation causes tumor regression in Walker 256 tumor-bearing rats

Scientific ReportsNovember 11, 2019
Wilson Mitsuo Tatagiba KuwabaraJosé Cipolla-Neto
Scientific Reports

Use of a Lymphatic Drug Delivery System and Sonoporation to Target Malignant Metastatic Breast Cancer Cells Proliferating in the Marginal Sinuses

Scientific ReportsSeptember 13, 2019
Shigeki KatoTetsuya Kodama
9
Frontiers in Microbiology

The Tol-Pal System of Uropathogenic Escherichia coli Is Responsible for Optimal Internalization Into and Aggregation Within Bladder Epithelial Cells, Colonization of the Urinary Tract of Mice, and Bacterial Motility

Frontiers in MicrobiologyAugust 7, 2019
Hidetada HirakawaHaruyoshi Tomita
4
The Breast Journal

Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience

The Breast JournalAugust 25, 2019
Faina NakhlisBeth A Overmoyer
Nature Communications

NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis

Nature CommunicationsSeptember 26, 2019
Nour ErshaidNeta Erez
24
1
Journal of Clinical Pathology

Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ

Journal of Clinical PathologyAugust 23, 2019
Michael S TossEmad A Rakha
3
1
3
Anti-cancer Agents in Medicinal Chemistry

Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer

Anti-cancer Agents in Medicinal ChemistryOctober 24, 2019
Mohamed A TantawyIsmail Abdelshafy Abdelhamid
Medicine

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report

MedicineSeptember 1, 2019
Giacomo BarchiesiPatrizia Vici
International Journal of Molecular Sciences

Salvianolic Acid B Slows the Progression of Breast Cancer Cell Growth via Enhancement of Apoptosis and Reduction of Oxidative Stress, Inflammation, and Angiogenesis

International Journal of Molecular SciencesNovember 12, 2019
Mohamed M KataryAhmed A Elmarakby
1
Cancer Biology & Medicine

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy

Cancer Biology & MedicineMay 1, 2019
Jing SiJiong Wu
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryOctober 31, 2019
Xiao-Rong XuDing-Kun Zhang
The Journal of Steroid Biochemistry and Molecular Biology

Bivalent furostene carbamates as antiproliferative and antiinflammatory agents

The Journal of Steroid Biochemistry and Molecular BiologyAugust 28, 2019
Nandini PathakArvind Singh Negi
Spine

Increased Fibrogenic Gene Expression in Multifidus Muscles of Patients with Chronic Versus Acute Lumbar Spine Pathology

SpineSeptember 10, 2019
Bahar ShahidiSamuel R Ward
Kaku igaku. The Japanese journal of nuclear medicine

Effectiveness of Strontium-89 for Neuropathic Pain Caused by Bone Metastases from Breast Cancer: A Case Report

Kaku igaku. The Japanese journal of nuclear medicineJanuary 1, 2019
Yusuke IizukaTakashi Mizowaki
Oxidative Medicine and Cellular Longevity

Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer

Oxidative Medicine and Cellular LongevityAugust 8, 2019
Bruno Ricardo Barreto PiresEliana Abdelhay
Veterinary Pathology

P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas

Veterinary PathologySeptember 19, 2019
Michela LeviGiuseppe Sarli
BMC Cancer

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis

BMC CancerAugust 23, 2019
Liang ZengYong-Guang Tao

See more papers from this feed

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

© 2019 Meta ULC. All rights reserved
/feed-previews/inflammatory-breast-neoplasms/194cc0d6-0d1a-4fd5-ba39-b1d8b1c02861